Sex Hormones as Novel Risk Biomarkers for Atherosclerosis in Peripheral Vascular Disease**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 50, Issue 11, 2007, Pages 1077-1079

  Liu, Peter P ^a,b,c   Fukuoka, Masahiro ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; BIOLOGICAL MARKER; ESTROGEN; TESTOSTERONE;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG MECHANISM; EDITORIAL; ELDERLY CARE; HUMAN; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MENOPAUSAL SYNDROME; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SMOKING HABIT; STABLE ANGINA PECTORIS;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; ESTRADIOL; HUMANS; PERIPHERAL VASCULAR DISEASES; TESTOSTERONE;

EID: 34548458638     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.05.031     Document Type: Editorial

References (14)

1. Tivesten Å., Mellström D., Jutberger H., et al. Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men: the MrOS study in Sweden. J Am Coll Cardiol 50 (2007) 1070-1076
2. Shabsigh R., Katz M., Yan G., and Makhsida N. Cardiovascular issues in hypogonadism and testosterone therapy. Am J Cardiol 96 (2005) 67M-72M
3. English K.M., Steeds R.P., Jones T.H., Diver M.J., and Channer K.S. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 102 (2000) 1906-1911
4. Phillips G.B., Castelli W.P., Abbott R.D., and McNamara P.M. Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort. Am J Med 74 (1983) 863-869
5. Tivesten A., Hulthe J., Wallenfeldt K., Wikstrand J., Ohlsson C., and Fagerberg B. Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men. J Clin Endocrinol Metab 91 (2006) 4433-4437
6. Ouyang P., Michos E.D., and Karas R.H. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J Am Coll Cardiol 47 (2006) 1741-1753
7. Maret A., Coudert J.D., Garidou L., et al. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur J Immunol 33 (2003) 512-521
8. Seli E., Guzeloglu-Kayisli O., Cakmak H., Kayisli U.A., Selam B., and Arici A. Estradiol increases apoptosis in human coronary artery endothelial cells by up-regulating Fas and Fas ligand expression. J Clin Endocrinol Metab 91 (2006) 4995-5001
9. Villablanca A., Lubahn D., Shelby L., Lloyd K., and Barthold S. Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor alpha. Arterioscler Thromb Vasc Biol 24 (2004) 1055-1061
10. Alexandersen P., Haarbo J., Byrjalsen I., Lawaetz H., and Christiansen C. Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 84 (1999) 813-819
11. Norata G.D., Tibolla G., Seccomandi P.M., et al. Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells. J Clin Endocrinol Metab 91 (2006) 546-554
12. Kapoor D., Malkin C.J., Channer K.S., and Jones T.H. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) 63 (2005) 239-250
13. Snyder P.J., Peachey H., Berlin J.A., et al. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 85 (2000) 2670-2677
14. Lin H.Y., Xu Q., Yeh S., Wang R.S., Sparks J.D., and Chang C. Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes 54 (2005) 1717-1725